Remove Family Practice Remove Information Remove Medical Remove Primary Care
article thumbnail

Practice patterns of Ontario physicians working in 'boutique' medical clinics [Economic or policy analysis]

Annals of Family Medicine

Context: In Ontario, multiple organizations operate under a ‘boutique’ medicine model where patients pay a block or annual fee to access primary care services. Little is known about the characteristics of physicians and patients participating in boutique clinic practice models.

Clinic 130
article thumbnail

Using EMR data to describe administrative workload of primary care providers in Nova Scotia, Canada [Secondary data analysis]

Annals of Family Medicine

Context: Primary care providers in Canada face significant workload challenges, including managing prescriptions, referrals, and laboratory tests alongside patient visits. This study aims to analyze electronic medical record (EMR) data to understand these workload dynamics. 0.9SD) encounters per patient since 2007.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supporting Healthy Aging With Tailored Obesity Management Strategies

Physician's Weekly

Given practical constraints in many healthcare settings, who are the minimum essential team members for multidisciplinary management of weight loss in older adults? How might primary care physicians coordinate this care in settings with limited specialist access?

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. More Information Copyright © 2025 HealthDay. ” The approval of Widaplik was granted to George Medicines.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

It’s “going to streamline it in some incremental ways only,” Dr. Adam Gaffney , a critical care doctor and assistant professor at Harvard Medical School, told NBC News. Insurers must provide clearer explanations when care is denied and explain how patients can appeal. But experts say the changes may not go far enough.

article thumbnail

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

Physician's Weekly

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Abstract/Full Text (subscription or payment may be required) More Information Copyright © 2025 HealthDay.

article thumbnail

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

Physician's Weekly

But the FDA has never approved it for any medical condition in the U.S. “You never quite know what’s in that bottle,” Dr. Diane Calello of the New Jersey Poison Information and Education System told the AP. More information The U.S. It cannot legally be sold as a dietary supplement or added to foods or drinks.

Medical 52